Clinical Trial Update: Safety and Efficacy of Solithromycin in the Treatment of Nonalcoholic Steatohepatitis Without Cirrhosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial results assessing safety and efficacy of solithromycin in nonalcoholic steatohepatitis without cirrhosis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• Solithromycin (solithromycin)

Snippet

Sponsor: Melinta Therapeutics, Inc. | Conditions: Nonalcoholic Steatohepatitis | Phase 2 | Status: COMPLETED